125 related articles for article (PubMed ID: 28670139)
1. Younger age is an independent predictor of worse prognosis among Lebanese nonmetastatic breast cancer patients: analysis of a prospective cohort.
El Chediak A; Alameddine RS; Hakim A; Hilal L; Abdel Massih S; Hamieh L; Mukherji D; Temraz S; Charafeddine M; Shamseddine A
Breast Cancer (Dove Med Press); 2017; 9():407-414. PubMed ID: 28670139
[TBL] [Abstract][Full Text] [Related]
2. The impact of young age (< 40 years) on the outcome of a cohort of patients with primary non-metastatic breast cancer: analysis of 10-year survival of a prospective study.
Bouferraa Y; Haibe Y; Chedid A; Jabra E; Charafeddine M; Temraz S; Mukherji D; El Saghir N; Shamseddine A
BMC Cancer; 2022 Jan; 22(1):27. PubMed ID: 34980002
[TBL] [Abstract][Full Text] [Related]
3. Luminal B subtype: a key factor for the worse prognosis of young breast cancer patients in China.
Tang LC; Jin X; Yang HY; He M; Chang H; Shao ZM; Di GH
BMC Cancer; 2015 Mar; 15():201. PubMed ID: 25885213
[TBL] [Abstract][Full Text] [Related]
4. [Clinical features and prognosis of patients with first-episode liver metastasis of different molecular subtypes of breast cancer].
Wu SY; Tan Y; Guan YS
Zhonghua Gan Zang Bing Za Zhi; 2016 Jun; 24(6):422-8. PubMed ID: 27465945
[TBL] [Abstract][Full Text] [Related]
5. Young age at diagnosis is associated with worse prognosis in the Luminal A breast cancer subtype: a retrospective institutional cohort study.
Liu Z; Sahli Z; Wang Y; Wolff AC; Cope LM; Umbricht CB
Breast Cancer Res Treat; 2018 Dec; 172(3):689-702. PubMed ID: 30225619
[TBL] [Abstract][Full Text] [Related]
6. Body mass index, PAM50 subtype, recurrence, and survival among patients with nonmetastatic breast cancer.
Cespedes Feliciano EM; Kwan ML; Kushi LH; Chen WY; Weltzien EK; Castillo AL; Sweeney C; Bernard PS; Caan BJ
Cancer; 2017 Jul; 123(13):2535-2542. PubMed ID: 28295245
[TBL] [Abstract][Full Text] [Related]
7. Hepatosteatosis may predict late recurrence of breast cancer: A single-center observational study.
Kus T; Cinkir HY; Aktas G; Abali H
Curr Probl Cancer; 2019 Dec; 43(6):100461. PubMed ID: 30686567
[TBL] [Abstract][Full Text] [Related]
8. Outcome following local-regional recurrence in women with early-stage breast cancer: impact of biologic subtype.
Braunstein LZ; Niemierko A; Shenouda MN; Truong L; Sadek BT; Abi Raad R; Wong JS; Punglia RS; Taghian AG; Bellon JR
Breast J; 2015; 21(2):161-7. PubMed ID: 25559656
[TBL] [Abstract][Full Text] [Related]
9. Prognostic assessment of breast carcinoma submitted to neoadjuvant chemotherapy with pathological non-complete response.
Resende U; Cabello C; Ramalho SOB; Zeferino LC
BMC Cancer; 2019 Jun; 19(1):601. PubMed ID: 31208353
[TBL] [Abstract][Full Text] [Related]
10. Improved clinical outcomes associated with vitamin D supplementation during adjuvant chemotherapy in patients with HER2+ nonmetastatic breast cancer.
Zeichner SB; Koru-Sengul T; Shah N; Liu Q; Markward NJ; Montero AJ; Glück S; Silva O; Ahn ER
Clin Breast Cancer; 2015 Feb; 15(1):e1-11. PubMed ID: 25241299
[TBL] [Abstract][Full Text] [Related]
11. Progesterone receptor loss identifies hormone receptor-positive and HER2-negative breast cancer subgroups at higher risk of relapse: a retrospective cohort study.
Sun JY; Wu SG; Li FY; Lin HX; He ZY
Onco Targets Ther; 2016; 9():1707-13. PubMed ID: 27051305
[TBL] [Abstract][Full Text] [Related]
12. [Long-term survival analysis of different breast cancer molecular subtypes: Shanghai Breast Cancer Survival Study].
Bao P; Peng P; Gu K; Wu C; Huang Z; Gong Y; Zhang M; Zheng Y
Zhonghua Wai Ke Za Zhi; 2015 Dec; 53(12):928-34. PubMed ID: 26850665
[TBL] [Abstract][Full Text] [Related]
13. [Clinical characteristics and survival in the operable breast cancer patients with different molecular subtypes].
Zhang HM; Zhang BN; Xuan LX; Zhao P
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):447-51. PubMed ID: 19950556
[TBL] [Abstract][Full Text] [Related]
14. Relationship of pathological features and a 21 gene expression assay in younger versus older women with node-negative endocrine receptor-positive breast cancer.
Mutonga M; Speedy S; Rademaker A; Liu D; Uthe R; Jain S; Gradishar WJ; Flaum L; Santa-Maria CA
Breast Cancer Res Treat; 2019 Jul; 176(1):95-100. PubMed ID: 30977026
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer-specific survival by clinical subtype after 7 years follow-up of young and elderly women in a nationwide cohort.
Johansson ALV; Trewin CB; Hjerkind KV; Ellingjord-Dale M; Johannesen TB; Ursin G
Int J Cancer; 2019 Mar; 144(6):1251-1261. PubMed ID: 30367449
[TBL] [Abstract][Full Text] [Related]
16. The Impact of Young Age for Prognosis by Subtype in Women with Early Breast Cancer.
Lian W; Fu F; Lin Y; Lu M; Chen B; Yang P; Zeng B; Huang M; Wang C
Sci Rep; 2017 Sep; 7(1):11625. PubMed ID: 28912475
[TBL] [Abstract][Full Text] [Related]
17. Different prognosis of young breast cancer patients in their 20s and 30s depending on subtype: a nationwide study from the Korean Breast Cancer Society.
Ryu JM; Yu J; Kim SI; Kim KS; Moon HG; Choi JE; Jeong J; Do Byun K; Nam SJ; Lee JE; Lee SK; Kim SW
Breast Cancer Res Treat; 2017 Dec; 166(3):833-842. PubMed ID: 28831642
[TBL] [Abstract][Full Text] [Related]
18. Association of Tobacco Use, Alcohol Consumption and HER2 Polymorphisms With Response to Trastuzumab in HER2-Positive Breast Cancer Patients.
Furrer D; Jacob S; Michaud A; Provencher L; Lemieux J; Diorio C
Clin Breast Cancer; 2018 Aug; 18(4):e687-e694. PubMed ID: 29275864
[TBL] [Abstract][Full Text] [Related]
19. Molecular Subtypes and Prognostic Factors among Premenopausal and Postmenopausal Thai Women with Invasive Breast Cancer: 15 Years Follow-up Data.
Tubtimhin S; Promthet S; Suwanrungruang K; Supaattagorn P
Asian Pac J Cancer Prev; 2018 Nov; 19(11):3167-3174. PubMed ID: 30486605
[TBL] [Abstract][Full Text] [Related]
20. Preoperative CA 15-3 levels predict the prognosis of nonmetastatic luminal A breast cancer.
Li H; Chen K; Su F; Song E; Gong C
J Surg Res; 2014 Jun; 189(1):48-56. PubMed ID: 24680287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
